Clinical trial
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
NCT00389935 · Northport Veterans Affairs Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00389935 |
|---|---|
| Title | Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding |
| Official title | Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding |
| Acronym | TAG |
| Lead sponsor | Northport Veterans Affairs Medical Center, U.S. Fed |
| Collaborators | Augusta University University of Massachusetts, Worcester |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arteriovenous Malformation, Hereditary Hemorrhagic Telangiectasia, Hematochezia, Melena |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 14 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Oct 19, 2006 |
| Last update posted | Aug 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: